US4444878A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Bispecific antibody determinants
Assignee: Boston Biomedical Research Institute
•
Filing: 1981-12-21
•
Granted: 1984-04-24
•
Expires: 2001-12-21
Abstract
Abstract A homogenous sample of identical bispecific antibody determinants, each determinant being composed of two L-H half-molecules linked by disulfide bonds, each L-H half-molecule being specific for a different antigenic determinant and including at least the F(ab') portion of a monoclonal IgG antibody. The bispecific antibody determinants are useful, e.g., in the formation of multilamellar assemblies and enzyme electrodes.
Inventors
- 👤 Henry P. Paulus
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 14:42
CPC Classifications
C; C08; C08L; C08L35/00; C08L35/04; C07; C07K; C07K16/00; C07K16/46; C07K16/468; C08L55/00; C08L55/02; C08L65/00; C12; C12Q; C12Q1/00; C12Q1/001; C12Q1/002; C12Q1/003; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/563; Y; Y10; Y10S; Y10S435/00; Y10S435/805; Y10S435/81; Y10S435/817; Y10S435/962; Y10S435/964; Y10S435/966; Y10S435/969; Y10S436/00; Y10S436/807; Y10S436/808
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
221 words
A homogenous sample of identical bispecific antibody determinants, each said determinant comprising two L-H half-molecules linked by disulfide bonds, each said L-H half-molecule being specific for a different antigenic determinant, and comprising at least the F(ab') portion of a monoclonal IgG antibody, one said antigenic determinant comprising an antigenic site on a solid matrix, whereby said bispecific antibody determinant is capable of being immobilized on said solid matrix by binding to said matrix at said antigenic site, said sample comprising a multilamellar assembly wherein said antigenic site on said matrix is a site on a haptenic molecule attached to said matrix, said bispecific antibody determinant is bonded to said haptenic molecule, the other said antigenic determinant comprises a first antigenic site on a first protein molecule, said bispecific antibody determinant being bonded to said protein molecule, and there is bonded to said first protein molecule, at a second antigenic site on said protein molecule, a second bispecific antibody determinant different from the determinant bonded to said haptenic molecule, each said second determinant comprising two L-H half molecules linked by disulfide bonds, each said L-H half molecule being specific for a different antigenic determinant, one said antigenic determinant being a second antigenic site on said first protein molecule, each said half-molecule comprising at least the F(ab') portion of a monoclonal IgG antibody.
Claim 2
Dependent Claim
221 words
A homogenous sample of identical bispecific antibody determinants, each said determinant comprising two L-H half-molecules linked by disulfide bonds, each said L-H half-molecule being specific for a different antigenic determinant, and comprising at least the F(ab') portion of a monoclonal IgG antibody, one said antigenic determinant comprising an antigenic site on a solid matrix, whereby said bispecific antibody determinant is capable of being immobilized on said solid matrix by binding to said matrix at said antigenic site, said sample comprising a multilamellar assembly wherein said antigenic site on said matrix is a site on a haptenic molecule attached to said matrix, said bispecific antibody determinant is bonded to said haptenic molecule, the other said antigenic determinant comprises a first antigenic site on a first protein molecule, said bispecific antibody determinant being bonded to said protein molecule, and there is bonded to said first protein molecule, at a second antigenic site on said protein molecule, a second bispecific antibody determinant different from the determinant bonded to said haptenic molecule, each said second determinant comprising two L-H half molecules linked by disulfide bonds, each said L-H half molecule being specific for a different antigenic determinant, one said antigenic determinant being a second antigenic site on said first protein molecule, each said half-molecule comprising at least the F(ab') portion of a monoclonal IgG antibody.
Claim 3
Dependent Claim
29 words
The assembly of claim 1 wherein the other said antigenic determinant for which said second bispecific antibody determinant is specific is an antigenic site on a second protein molecule.
Claim 4
Dependent Claim
15 words
The assembly of claim 2 wherein each said first and second protein is an enzyme.
Claim 5
Dependent Claim
44 words
The assembly of claim 3 wherein said assembly is useful for the measurement of a substance, and said enzymes participate in a series of reactions which result in the production, from said substance, of a measurable effect which is a measure of said substance.
Claim 6
Dependent Claim
219 words
Electrode apparatus for the measurement in a sample of an unknown amount of a substance which is acted on by one or more enzymes to evolve a measurable ion or compound, said ion or compound evolved being a measure of said unknown substance, said electrode apparatus comprising means for measuring said measurable ion or compound, and, associated with said means for measuring said measurable ion or compound, a membrane having associated therewith a plurality of molecules of each said enzyme which acts on said substance to be measured and, bonded to the molecules of each said enzyme, a plurality of identical, bispecific antibody determinants, each said determinant comprising two L-H half-molecules linked by disulfide bonds, each said half-molecule being different from the other and comprising at least the F(ab') portion of a monoclonal IgG antibody, one said L-H half-molecule being specific for an antigenic site on the enzyme molecule to which it is bonded, the other half-molecule being specific for an antigenic determinant on said membrane, said bispecific antibody determinant being bonded thereto, wherein said substance to be measured is acted on by more than one enzyme, and the molecules of at least one of said enzymes are bonded to half-molecule of each of two different said bispecific antibody determinants at two different antigenic sites on said enzyme molecules.
Claim 7
Dependent Claim
219 words
Electrode apparatus for the measurement in a sample of an unknown amount of a substance which is acted on by one or more enzymes to evolve a measurable ion or compound, said ion or compound evolved being a measure of said unknown substance, said electrode apparatus comprising means for measuring said measurable ion or compound, and, associated with said means for measuring said measurable ion or compound, a membrane having associated therewith a plurality of molecules of each said enzyme which acts on said substance to be measured and, bonded to the molecules of each said enzyme, a plurality of identical, bispecific antibody determinants, each said determinant comprising two L-H half-molecules linked by disulfide bonds, each said half-molecule being different from the other and comprising at least the F(ab') portion of a monoclonal IgG antibody, one said L-H half-molecule being specific for an antigenic site on the enzyme molecule to which it is bonded, the other half-molecule being specific for an antigenic determinant on said membrane, said bispecific antibody determinant being bonded thereto, wherein said substance to be measured is acted on by more than one enzyme, and the molecules of at least one of said enzymes are bonded to half-molecule of each of two different said bispecific antibody determinants at two different antigenic sites on said enzyme molecules.
Claim 8
Dependent Claim
220 words
Electrode apparatus for the measurement in a sample of an unknown amount of a substance which is acted on by one or more enzymes to evolve a measurable ion or compound, said ion or compound evolved being a measure of said unknown substance, said electrode apparatus comprising means for measuring said measurable ion or compound, and, associated with said means for measuring said measurable ion or compound, a membrane having associated therewith a plurality of molecules of each said enzyme which acts on said substance to be measured and, bonded to the molecules of each said enzyme, a plurality of identical, bispecific antibody determinants, each said determinant comprising two L-H half-molecules linked by disulfide bonds, each said half-molecule being different from the other and comprising at least the F(ab') portion of a monoclonal IgG antibody, one said L-H half-molecule being specific for an antigenic site on the enzyme molecule to which it is bonded, the other half-molecule being specific for an antigenic determinant on said membrane, said bispecific antibody determinant being bonded thereto, wherein said substance to be measured is lactose, said enzymes are β-galactosidase and glucose oxidase, and said measurable compound is oxygen, wherein the molecules of said glucose oxidase are bonded to two different said bispecific antibody determinants at two different antigenic sites on said glucose oxidase molecules.
Claim 9
Dependent Claim
220 words
Electrode apparatus for the measurement in a sample of an unknown amount of a substance which is acted on by one or more enzymes to evolve a measurable ion or compound, said ion or compound evolved being a measure of said unknown substance, said electrode apparatus comprising means for measuring said measurable ion or compound, and, associated with said means for measuring said measurable ion or compound, a membrane having associated therewith a plurality of molecules of each said enzyme which acts on said substance to be measured and, bonded to the molecules of each said enzyme, a plurality of identical, bispecific antibody determinants, each said determinant comprising two L-H half-molecules linked by disulfide bonds, each said half-molecule being different from the other and comprising at least the F(ab') portion of a monoclonal IgG antibody, one said L-H half-molecule being specific for an antigenic site on the enzyme molecule to which it is bonded, the other half-molecule being specific for an antigenic determinant on said membrane, said bispecific antibody determinant being bonded thereto, wherein said substance to be measured is lactose, said enzymes are β-galactosidase and glucose oxidase, and said measurable compound is oxygen, wherein the molecules of said glucose oxidase are bonded to two different said bispecific antibody determinants at two different antigenic sites on said glucose oxidase molecules.
References Cited (Backward Citations)
JPS50155678A
Cited
US4193982A
Cited
US4200436A
Cited
US4208479A
Cited
US4240889A
Cited
US4298685A
Cited
US4235869A
Cited
US4340535A
Cited
US4223005A
Cited
US4350626A
Cited
US4278761A
Cited
US4331647A
Cited
US4376110A
Cited
EP0068763A2
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-04-24 | 1987-10-24 | 1988-04-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-04-24 | 1991-10-24 | 1992-04-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-04-24 | 1995-10-24 | 1996-04-24 | $7700.00 | Window Closed / Lapsed |